Dulaglutide and Insulin MicrosecretiON in Type 1 Diabetes

NCT03668470 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Adult Subjects With Type1Diabetes and Insulin Microsecretion

Interventions

DRUG: Dulaglutide
DRUG: Placebo

Sponsor

Hospices Civils de Lyon